Gladstone Capital presents mixed signals as it approaches its next earnings report. Read what makes GLAD stock a hold, not a ...

The 60/40 portfolio has been the go-to diversified portfolio for investors, but it has been underperforming in the past ...

The Oncology Institute's stock surged 900% amid insider buying, despite cash burn, unprofitability, and potential need for ...

Detractors reduce DEI to racist rhetoric and bureaucratic bloat. The vision they invoke is an unkind caricature. A distortion. A fiction.